★ Neuropeptides

Oxytocin

Neuropeptides · 2mg × 10 vials

Neuropeptide hormone. Studied in social-cognition, bonding and anxiety models.

✓ 98%+ Purity ✓ Lab Tested ✓ COA on Request ✓ Discreet Shipping ✓ Direct Support
📋 Certificate of Analysis Request the third-party COA via Telegram ↗
Pricing
$85from · 10-vial kit
Shipping: $40 US · $60 international (10-vial kits only) · single vials $20, US only · free over $1,000
2mg × 10 vials$85
5mg × 10 vials$90
10mg × 10 vials$120
Order / Consult on Telegram →
~3-5 min (systemic plasma); central CNS effect window ~30-90 min intranasal
Half-life
nootropic
Class
Overview

What Is Oxytocin?

Oxytocin is a nine-amino-acid neuropeptide synthesised in the hypothalamus and released by the posterior pituitary. It acts on the oxytocin receptor (OXTR), a G-protein-coupled receptor densely expressed in the amygdala, nucleus accumbens, and prefrontal cortex, and in peripheral tissues including the uterus, mammary gland, and cardiovascular system.

Centrally, OXTR activation modulates social behaviour in three documented ways: it dampens amygdala threat response, increases ventral striatum reward signalling in response to social cues, and enhances theory-of-mind processing (recognition of social and emotional cues in others). Peripherally, oxytocin drives uterine contraction in labour and milk ejection in lactation, its approved clinical uses. Research interest centres on the central effects, with trials in social anxiety, autism spectrum conditions, and couples-therapy adjuncts. Systemic half-life is a few minutes, and oxytocin crosses the blood-brain barrier poorly from circulation, which is why the intranasal route dominates the research literature: it reaches the brain via the cribriform plate.

Published Safety Data

What the published studies measured.

What the studies show
Measured in clinical trials
  • Subjective: most intranasal social/anxiety trials report no measurable AE rate above placebo at 20-40 IU single-dose protocols. This is one of the safer peptides on paper at research doses.
  • Headache: 5-10% across IN trials, mild
  • Nasal irritation: ~5% IN, transient
  • Mild sleepiness/fatigue: ~5-10%, especially at higher doses
  • Mild nausea: low single digits IN, higher at SubQ doses approaching obstetric range
  • Mood flattening / emotional blunting at supra-physiological doses: documented signal in some social-cognition trials, the so-called "dark side of oxytocin" papers (increased in-group/out-group bias, reduced trust in untrustworthy faces, occasional irritability)
  • Peripheral (obstetric Pitocin context, NOT relevant at IN research doses): uterine contraction, water retention/hyponatremia at high IV doses, transient BP changes
  • Bart-Hampton autism IN trials (4 IU/kg pediatric, ~80-200 IU/day continuous, which is far above the exposures reported outside trials): no significant AE signal over placebo across 12-week protocols. Adults at 20-40 IU pulsed dosing are well below this threshold.
The Research

Peer-reviewed studies and clinical guidelines - tap any to read the source.

PubMedKosfeld et al, Oxytocin increases trust in humans, Nature 2005

foundational trust/social-bonding intranasal trial, 24 IU dose

Read study ↗
PubMedDomes et al, Oxytocin attenuates amygdala responses to emotional faces, Biol Psychiatry 2007

amygdala-damping mechanism for the social-anxiety effect

Read study ↗
PubMedMeyer-Lindenberg et al, Oxytocin and vasopressin in the human brain, Nat Rev Neurosci 2011

review of central OXTR signaling and social cognition

Read study ↗
PubMedYatawara et al, Effect of oxytocin nasal spray on social responsiveness in autism, Mol Psychiatry 2016

pediatric autism trial, 12-week IN protocol, mixed efficacy with strong safety signal

Read study ↗
PubMedSippel et al, Oxytocin and PTSD review, Curr Treat Options Psychiatry 2017

PTSD adjunctive use, mixed but promising data, particularly for trauma with relational disruption

Read study ↗
PubMedBehnia et al, Differential effects of intranasal oxytocin on sexual experiences in heterosexual couples, Horm Behav 2014

intimacy/sexual-experience trial in couples, the canonical intimacy-enhancement reference

Read study ↗
+ 6 more studies & references

Reconstitution & Storage

Storage: refrigerated, stable ~14-21 days reconstituted. This is shorter than most peptides, oxytocin is genuinely fragile in aqueous solution and degrades faster at room temp. Lyophilized vials room-temp short-term, refrigerate for long storage. Freezing in single-use aliquots extends usable life past 30 days for infrequent use.

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.